NCT06625307View on ClinicalTrials.gov

A Research Study on the Effects of NNC0537-1482 in Healthy Individuals When Injected Under the Skin

PHASE1CompletedINTERVENTIONAL

Enrollment

31

Participants

Timeline

Start Date

October 3, 2024

Primary Completion Date

May 4, 2025

Study Completion Date

May 4, 2025

Conditions

Healthy VolunteersHeart Failure

Interventions

DRUG

NNC0537-1482

Administered via subcutaneous route

DRUG

Placebo

Administered via subcutaneous route

Trial Locations (1)

9728 NZ

ICON - location Groningen, Groningen

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY